具有可注射和自我愈合性能的超敏感pH响应水凝,用于控制药物输送
Yang Yu1,2, Yili Zhao2, Yujiao Zou2
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
International journal of pharmaceutics: X
|September 10, 2025
概括
为癌症治疗开发了一种新的pH响应型水凝. 这种药物输送系统在瘤微环境中显示了多克索鲁比辛的超敏感释放,提高了化疗的有效性.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 癌症治疗 癌症治疗
背景情况:
- 开发响应pH的水凝对于向的癌症治疗至关重要.
- 瘤微环境呈现轻微酸性pH值,非常适合向药物释放.
研究的目的:
- 为了合成和表征一种超敏感的pH响应的凝,用于输送多克索鲁比.
- 为了评估水凝在模拟瘤微环境中的性能.
主要方法:
- 合成4-甲基酸改性聚乙烯醇 (PVA-FBA) 并与聚乙烯胺 (PEI) 交联,形成载有多克索鲁比的PVA-FBA/PEI水凝 (D-PFP).
- 描述水凝的特性,包括结构稳定性,形态学和不同pH值 (7.4和6.8) 的药物释放动力学.
- 评估了可注射性,自我愈合性,细胞相容性和抗癌活性.
主要成果:
- 使用PF-0.25聚合物和特定的前体/PEI度确定了最佳的水凝制备条件.
- 在pH 7.4时,D-PFP水凝显示药物泄漏最小,在pH 6.8时释放显著更高,表明pH敏感度高.
- 水凝表现出良好的结构完整性,可注射性,自我愈合能力,优异的细胞相容性和强大的癌细胞抑制.
结论:
- 开发的D-PFP水凝是一种超敏感的,对pH值有反应的药物输送系统.
- 它的特性使其成为癌症治疗中向化疗应用的有希望的候选人.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


